Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2931
https://www.valueinhealthjournal.com/article/S1098-3015(15)05012-3/fulltext
Section Title : Research Podium Presentations - Session 1 and Session 2
Section Order : 2335
First Page : A755
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)05012-3&doi=10.1016/j.jval.2015.09.2931
HEOR Topics :
Tags :
Regions :